Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Dyax issued U.S. patent for novel elastase inhibitors

Oct. 2, 1997

Antileukotriene effects described for ebastine

Oct. 1, 1997

Peptidoleukotrienes and TxA2 both implicated in cough variant asthma

Oct. 1, 1997

Protective effects of Bayer's LTD4 antagonist demonstrated in asthmatic subjects

Oct. 1, 1997

Inhibitors of sCD23 production developed at SmithKline Beecham

Sep. 30, 1997

Zeneca describes SAR for new asthma therapy in development

Sep. 29, 1997

Arris reports data from phase IIa asthma trial

Sep. 26, 1997

CMI-947: new 5-LO inhibitor discovered at CytoMed

Sep. 26, 1997

Synthetic studies on LAS-32521 reported

Sep. 26, 1997

Novel benzothiazolone ethanamines for airways diseases

Sep. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...